The AANS/CNS Drugs and Devices Committee is actively engaged with the Food and Drug Administration (FDA) and other scientific, governmental, clinical and industry representatives to provide neurosurgical expertise on drugs, devices and biologics used to treat patients and to foster innovation and patient safety. These activities include recommending neurosurgeon experts to serve on the FDA Advisory panels, providing input on FDA Guidance Documents and testimony at panel meetings, as appropriate. In addition, organized neurosurgery is an official partner with the FDA's Network of Experts program to provide rapid clinical assistance to FDA reviewers. The AANS and CNS continue to advocate policies that will decrease the regulatory burden for medical-device innovation and ensure patient access to new and improved medical technology.
Letters
Published: December 3, 2018
Dear Administrator Verma: The undersigned physician organizations representing both national medical societies and state medicalsocieties are writing in response to the Centers for Medicare & Medicaid Services (CMS) request forfeedback […]
Letters
Published: September 18, 2018
Dear Leader McConnell, Leader Schumer, Speaker Ryan, and Leader Pelosi: Thank you for your leadership in combatting the opioid epidemic. The undersigned organizations represent adiverse group of stakeholders across the […]
Letters
Published: September 18, 2018
Dear Chairman Walden and Ranking Member Pallone: The undersigned organizations, representing a cross-section of medical specialties, write toreiterate our strong support for protecting our patients by aligning 42 CFR Part […]
Article
Published: September 7, 2018
Re: Memo of August 7th Regarding Prior Authorization and Step Therapy for Part B Drugs inMedicare Advantage The undersigned organizations representing physicians thank the Centers for Medicare and MedicaidServices (CMS) […]
Letters
Published: August 16, 2018
Subject: Docket FDA-2018-N-1315 Medical Device Safety Action Plan: ProtectingPatients and Promoting Public Health. Dear Dr. Gottlieb, The American Association of Neurological Surgeons (AANS) and Congress of Neurological Surgeons(CNS) appreciate the […]
Article
Published: August 9, 2018
In 2014, the AMA Opioid Task Force convened to coordinate efforts that were underway withinorganized medicine to help end the nation’s opioid epidemic. Together, the Task Force identifiedsix recommendations focused […]
Letters
Published: March 27, 2018
SUBJECT: H.R. 4482, the Opioid Abuse Deterrence, Research, and Recovery Act Dear Representatives Meadows and Renacci: On behalf of the American Association of Neurological Surgeons (AANS) and Congress of NeurologicalSurgeons […]
Letters
Published: March 20, 2018
SUBJECT: H.R.5311, the CARA 2.0 Act of 201 Dear Representatives Blackburn, Ryan, MacArthur and Kuster: On behalf of the American Association of Neurological Surgeons (AANS) and Congress of NeurologicalSurgeons (CNS), […]
Letters
Published: March 15, 2018
RE: Response to the Opioid Crisis Dear Chairman Brady, Ranking Member Neal, Chairman Roskam, and Ranking Member Levin: The Alliance of Specialty Medicine (the “Alliance”) represents more than 100,000 specialty […]
Letters
Subject: CMS-2017-0163, Advance Notice of Methodological Changes for Calendar Year(CY) 2019 for Medicare Advantage (MA) Capitation Rates, Part C and Part DPayment Policies and 2019 Draft Call Letter Dear Administrator […]
Article
Preview not available… … Read full article here
Article
Appropriate and reasonable regulatory decisions have provided access to groundbreaking newtechnologies for the treatment of brain aneurysms. These technologies have dramaticallyimproved patient care over the past two decades, ushering in […]
Letters
Published: February 28, 2018
SUBJECT: S. 2456, CARA 2.0 Act of 2018 Dear Senators Portman, Whitehouse, Capito, Klobuchar, Sullivan, Hassan, Cassidy and Cantwell: On behalf of the American Association of Neurological Surgeons (AANS) and […]
Letters
Published: February 16, 2018
Subject: AANS and CNS Feedback on Committee Questions Concerning PolicyRecommendations to Address Opioid and Substance Use Disorders. Dear Chairman Hatch and Ranking Member Wyden: The American Association of Neurological Surgeons […]
Letters
Published: February 5, 2018
Subject: Review of Existing Center for Devices and Radiological Health Regulatory andInformation Collection Requirements Dear Dr. Gottlieb, The American Association of Neurological Surgeons (AANS) and Congress of Neurological Surgeons(CNS) appreciate […]
Letters
Published: February 5, 2018
RE: Review of Existing Center for Drug Evaluation and Research Regulatory and InformationCollection Requirements Dear Dr. Gottlieb, The Alliance of Specialty Medicine (the “Alliance”) represents more than 100,000 specialtyphysicians from […]
Letters
Published: January 16, 2018
Re: Medicare Program; Contract Year 2019 Policy and Technical Changes to the MedicareAdvantage, Medicare Cost Plan, Medicare Fee-for-Service, the Medicare Prescription DrugBenefit Program, and the PACE Program Dear Administrator Verma, […]
Letters
Published: November 28, 2017
To the Members of the United States Senate and the United States House of Representatives: As the 114th Congress comes to a close and opportunities are emerging to introduce new […]
Letters
Published: November 16, 2017
Leader McConnell, Speaker Ryan, Leaders Schumer and Pelosi, and Members of Congress: On behalf of the millions of people who struggle to manage complex chronic and rare diseases,their families and […]
Article
Published: September 21, 2017
Help save lives: Co-prescribe naloxone to patients at risk of overdose Naloxone saves lives The nation’s opioid epidemic claimed more than 33,000lives in 2015, but that figure would have been […]
Article
Chairman King, Vice Chairman DeSantis, Ranking Member Cohen, and members of theSubcommittee, the Alliance of Specialty Medicine (the “Alliance”) thanks you for yourfocus on the issue of attorney advertising related […]
Letters
Dear Senator Cassidy and Senator Collins, As the authors of the Patient Freedom Act (S. 191) and as leaders in developing patient-focused health care policy,the Alliance of Specialty Medicine writes […]
Letters
Dear Mr. Chairman, Thank you for inviting the Alliance of Specialty Medicine to provide comments and recommendations related tothe Senate Finance Committee’s effort to produce patient-focused health care legislation. The […]
Letters
SUBJECT: Health Care Reform Dear Chairman Hatch: On behalf of the American Association of Neurological Surgeons (AANS) and Congress of NeurologicalSurgeons (CNS), we are writing to offer our thoughts on […]
Letters
Dear Commissioner Gottlieb: The undersigned members of the Alliance of Specialty Medicine write to congratulate you on your recentconfirmation as Commissioner of the Food and Drug Administration (FDA). As a […]
